Literature DB >> 16841620

Agitated "unipolar" major depression: prevalence, phenomenology, and outcome.

Mario Maj1, Raffaele Pirozzi, Lorenza Magliano, Andrea Fiorillo, Luca Bartoli.   

Abstract

OBJECTIVE: This study aimed to explore how prevalent agitated "unipolar" major depression is, whether it belongs to the bipolar spectrum, and whether it differs from nonagitated "unipolar" major depression with respect to course and outcome.
METHOD: The study was conducted from January 1, 1978, to December 31, 1996. From 361 patients with major depressive disorder, the authors selected those fulfilling Research Diagnostic Criteria for agitated depression. These 94 patients were compared to 94 randomly recruited patients with nonagitated major depressive disorder regarding demographic and historical features, the clinical characteristics of the index episode, the percentage of time spent in an affective episode during a prospective observation period, and the 5-year outcome. Patients with agitated major depressive disorder who had at least 2 manic/hypomanic symptoms in their index episode were compared to the other patients with agitated major depressive disorder with respect to the same variables.
RESULTS: Patients with agitated major depressive disorder were more likely to receive antipsychotics during their index episode and spent a higher proportion of time in an affective episode during the observation period compared with patients with nonagitated major depressive disorder. The presence of at least 2 manic/hypomanic symptoms in the index episode was associated with a higher rate of family history of bipolar I disorder, a higher score for suicidal thoughts during the episode, a longer duration of the episode, and a higher affective morbidity during the observation period.
CONCLUSION: The diagnosis of agitated major depressive disorder is not uncommon and has significant therapeutic and prognostic implications. The subgroup of patients with at least 2 manic/hypomanic symptoms may suffer from a mixed state and/or belong to the bipolar spectrum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16841620     DOI: 10.4088/jcp.v67n0504

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  16 in total

1.  Does psychomotor agitation in major depressive episodes indicate bipolarity? Evidence from the Zurich Study.

Authors:  Jules Angst; Alex Gamma; Franco Benazzi; Vladeta Ajdacic; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

2.  Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.

Authors:  Manish K Jha; Ashley L Malchow; Bruce D Grannemann; A John Rush; Madhukar H Trivedi
Journal:  Neuropsychopharmacology       Date:  2018-08-15       Impact factor: 7.853

Review 3.  Activated depression: mixed bipolar disorder or agitated unipolar depression?

Authors:  Alan C Swann
Journal:  Curr Psychiatry Rep       Date:  2013-08       Impact factor: 5.285

4.  The continuum/spectrum concept of mood disorders: is mixed depression the basic link?

Authors:  Franco Benazzi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09-07       Impact factor: 5.270

Review 5.  The significance of mixed states in depression and mania.

Authors:  Giulio Perugi; Giuseppe Quaranta; Liliana Dell'Osso
Journal:  Curr Psychiatry Rep       Date:  2014-10       Impact factor: 5.285

6.  Broadening the diagnosis of bipolar disorder: benefits vs. risks.

Authors:  Stephen M Strakowski; David E Fleck; Mario Maj
Journal:  World Psychiatry       Date:  2011-10       Impact factor: 49.548

7.  Effects of legal and illegal use of benzodiazepines at acute admission to a psychiatric acute department.

Authors:  John C Fløvig; Arne E Vaaler; Gunnar Morken
Journal:  BMC Res Notes       Date:  2010-10-19

8.  Continuum of depressive and manic mixed states in patients with bipolar disorder: quantitative measurement and clinical features.

Authors:  Alan C Swann; Joel L Steinberg; Marijn Lijffijt; Gerard F Moeller
Journal:  World Psychiatry       Date:  2009-10       Impact factor: 49.548

Review 9.  Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment.

Authors:  Leonardo Tondo; Ross J Baldessarini
Journal:  Curr Psychiatry Rep       Date:  2016-09       Impact factor: 5.285

Review 10.  Bipolar II disorder : epidemiology, diagnosis and management.

Authors:  Franco Benazzi
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.